Canakinumabin patients with COVID-19 and type 2 diabetes (CanCovDia) - a multicentric, randomised, double-blind, placebo-controlled phase 3 trial

Endocrine Abstracts(2022)

引用 0|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要